Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomization	STARTED	Tigecycline	235
Randomization	STARTED	Ceftriaxone	238
Randomization	COMPLETED	Tigecycline	232
Randomization	COMPLETED	Ceftriaxone	235
Randomization	NOT COMPLETED	Tigecycline	3
Randomization	NOT COMPLETED	Ceftriaxone	3
Baseline Participants	STARTED	Tigecycline	232
Baseline Participants	STARTED	Ceftriaxone	235
Baseline Participants	COMPLETED	Tigecycline	210
Baseline Participants	COMPLETED	Ceftriaxone	216
Baseline Participants	NOT COMPLETED	Tigecycline	22
Baseline Participants	NOT COMPLETED	Ceftriaxone	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00230971/flow